Alignment Healthcare, Inc.

8-K · alhc-20260604.htm iXBRL

0001832466 2026-06-04 2026-06-04

 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 _________________
 FORM 8-K
 _________________
 CURRENT REPORT
 Pursuant to Section 13 or 15(d)
 of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): June 4, 2026
 _______________________________
 ALIGNMENT HEALTHCARE, INC.
 (Exact name of registrant as specified in its charter)
 _______________________________

 Delaware 001-40295 46-5596242
 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

 1100 W. Town and Country Road , Suite 1600
 Orange , California 92868
 (Address of Principal Executive Offices) (Zip Code)
 ( 844 ) 310-2247
 (Registrant's telephone number, including area code)
 N/A
 (Former name or former address, if changed since last report)
 _______________________________
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:

 Title of each class Trading Symbol(s) Name of each exchange on which registered
 Common Stock, par value $0.001 per share ALHC The NASDAQ Stock Market LLC

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 Emerging growth company o
 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 Item 5.07. Submission of Matters to a Vote of Security Holders.

 The regular annual meeting of the stockholders (the "Annual Meeting") of Alignment Healthcare, Inc. (the "Company") was held virtually on June 4, 2026, for the purpose of voting on the proposals described below. There were 194,112,992 shares of common stock represented at the Annual Meeting. The stockholders of the Company voted as follows on the following matters at the Annual Meeting:

 Proposal 1: Election of Class II Directors.

 The three Class II directors were elected at the Annual Meeting based upon the following votes:

 Class I Director Name              For           Withhold    Broker Non-Vote
 Jody Bilney 135,714,231 42,598,200 15,800,560
 David Hodgson 108,386,550 69,925,881 15,800,560
 Jacqueline Kosecoff 135,613,817 42,698,614 15,800,560

 Each Class II director will serve a three-year term until the 2029 annual meeting or until his or her successor shall be elected and qualified.

 Proposal 2: Ratification of the Appointment of Deloitte & Touche LLP.

 The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified based upon the following votes:

 For Against Abstain
 194,030,577 13,893 68,522

 Proposal 3: Say-on-Pay Vote.

 On an advisory basis, the executive compensation of the Company’s named executive officers was approved based on the following votes:

 For Against Abstain Broker Non-Vote
 169,068,300 8,701,941 542,191 15,800,560

 SIGNATURE
 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 Alignment Healthcare, Inc.

 Date: June 9, 2026 By: /s/ Christopher Joyce
 Christopher Joyce
 Chief Legal & Administrative Officer